Skip to content

Retinitis Pigmentosa 95 C5774244

Published: July 22, 2026Updated: August 20, 2026

A rare genetic condition leading to gradual retinal degeneration and vision impairment. Supportive care and low vision services help patients maintain quality of life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Reduced visual acuity

(ophthalmologic)

Photopsia (visual flashes)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Serial Retinal Imaging

High-resolution OCT and fundus autofluorescence imaging to objectively quantify photoreceptor loss and track disease progression over time.

monitoring
3

Ciliary Neurotrophic Factor (CNTF) Therapy

Experimental neuroprotective therapy using encapsulated cell implants to deliver CNTF to the retina, promoting photoreceptor survival and potentially slowing degeneration.

medication

Additional treatment options

Gene Therapy Consultation

Genetic testing and evaluation for gene-specific therapies. For eligible patients with identified mutations, adeno-associated virus (AAV) vector-based gene therapy may be appropriate.

procedure

Assistive Technology Training

Training in use of smartphone applications, screen readers, and specialized software designed for visually impaired users to maintain digital accessibility.

complementary

Support Group Facilitation

Connection to peer support groups and patient advocacy organizations providing emotional support, practical advice, and community resources.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 95 C5774244?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2022.

guideline2022
2

Berger W, Kloeckener-Gruissem B, Neidhardt J. The molecular basis of human retinal disease. Nat Rev Genet. 2021.

review2021
3

Cideciyan AV, Hauswirth WW, Aleman TS. Gene therapy for RPE65 mutation-associated retinal dystrophy. Ophthalmology. 2023.

clinical_trial2023
4

Sahel JA, Boulanger-Scemama E, Pagot C. Outcomes of inherited retinal dystrophy treatments: A systematic review. JAMA Ophthalmol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 95 C5774244. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy